SCHEMBL27903555

SCHEMBL27903555

CCCN(CCC)CCCC(C(=O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 2/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ AKR1A1 P14550 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CA2 P00918 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ GPR84 Q9NQS5 3/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ KDM5A P29375 3/20 0.37
▸ CA12 O43570 2/20 0.37
▸ CA9 Q16790 2/20 0.37
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27886701 0.98 DRD3 (0.38) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL19223389 0.94 GPR84 (0.41) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL20007764 0.86 CHRM1 (0.42) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL15710769 0.84 SIGMAR1 (0.42) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL15711008 0.83 SIGMAR1 (0.41) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL15711065 0.80 TDP1 (0.45) TDP1MAPK1MAPTDRD2
SCHEMBL27914221 0.79 FOLH1 (0.47) DRD3CHRM1AKR1A1CHRM3HTR2A
SCHEMBL17102940 0.78 SIGMAR1 (0.50) CHRM1CHRM3GPR84FFAR1KDM5A
SCHEMBL30714400 0.77 GPR84 (0.47) GPR84FFAR1KDM5AMAPTLCK
SCHEMBL1131461 0.77 GPR84 (0.47) GPR84FFAR1KDM5AMAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103732601-B The one class treatment platinum compounds of cell proliferation disorders, its preparation method and application 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN disclosed
CN-102863474-A Platinum compounds for treating cell proliferative diseases and preparation method and application thereof CHEN XIAOPING 2013-01-09 — — CN disclosed
Send feedback